| Officer | Age | In this role | 2026 pay | Source |
|---|---|---|---|---|
|
Jason M. Hollar
Also a director
Chief Executive Officer
|
53 |
Since 2022
4 years
|
$22,574,349 | |
|
Aaron E. Alt
Chief Financial Officer
|
54 |
Since 2023
3 years
|
$6,860,173 | |
|
Valerie C. Pitteroff
Chief Human Resources Officer
|
55 |
Since 2026
this year
|
Not reported | |
|
Jessica L. Mayer
Chief Legal and Compliance Officer
|
57 |
Since 2019
7 years
|
$5,534,183 | |
|
Anita A Zielinski
Chief Accounting Officer
Title from the Form 3 dated Nov 6, 2026
|
Not stated | Not stated | Not reported | |
|
Deborah L. Weitzman
Chief Executive Officer, Pharma segment
|
61 |
Since 2022
4 years
|
$6,120,157 | |
|
Stephen M. Mason
Chief Executive Officer, GMPD segment
|
55 |
Since 2019
7 years
|
$5,293,365 | |
|
Michelle D. Greene
Executive Vice President, Chief Information Officer, and Customer Support Services
|
56 |
Since 2022
4 years
|
Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Sep 21, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...